Tuesday 7 May 2013

Top 10 Pharmaceutical Companies in India

In the list of top pharmaceutical companies in India it is not the Indian companies but also the MNCs that are becoming the part of the race. Indian pharmaceutical market in 2008 was $7,743m and if compared to year 2007 it was 4% more than that. It is expected that Indian pharmaceutical market will grow more than the global pharmaceutical market and will become $15,490 million in 2014. Today Indian pharmaceutical industry is the second most fastest growing industry displaying the revenue of Rs 25,196.48 crore and growth of 27.32 percent. Top pharmaceutical companies in India are also acquiring the small companies worldwide to further expand the market. Pharmaceutical drugs injections, tablets, capsules, syrups are the products of pharma companies in India along with many more.
top 10 pharma companies in india
  1. Ranbaxy Labs
    With total net sales of Rs 7686.59 crore, Ranbaxy is the largest pharmaceutical company in India.
  2. Cipla
    With total net sales of Rs 6,977.50 crore Cipla is the second largest pharmaceutical company in India.
  3. Dr Reddys Labs
    With total net sales of Rs 6,686.30 crore Dr Reddys Labs is the third largest pharmaceutical company in India.
  4. Lupin
    Lupin is the fourth largest pharma company in India with the total net sales of Rs 5,364.37 crore.
  5. Aurobindo Pharma
    Aurobindo Pharma is on 5th position with the total net sales of Rs 4,284.63 crore.
  6. Sun Pharma
    Net Sales revenues stood at Rs 4,015.56 crore makes it the sixth largest pharmaceutical company in India.
  7. Cadila Health
    Cadila Health is the seventh largest pharma company with the total sales revenue of Rs 3,152.20 crore.
  8. Jubilant Life
    Eight largest company has the total sale revenue at Rs 2,641.07 crore.
  9. Wockhardt
    Wockhardt has the total net sales of 2,560.16 crore and the ninth largest pharmaceutical company in India.
  10. Ipca Laboratories
    Revenue of Rs 2,352.59 crore makes Ipca India's 10th largest pharma firm by sales. 

No comments:

Post a Comment